Version 2.78

Term Description

This panel includes results for the three isomers of methylhippuric acid: meta-, ortho-, and para-methylhippurate. Their concentration levels in urine as well as the ratios to creatinine are measured to monitor occupational exposure to xylene, a hydrocarbon commonly used as a solvent. PMID: 8689499
Source: Regenstrief LOINC

Panel Hierarchy

Details for each LOINC in Panel LHC-Forms

LOINC Name R/O/C Cardinality Example UCUM Units
85097-4 Meta methylhippurate and ortho methylhippurate and para methylhippurate and creatinine panel - Urine
Indent82886-3 Meta methylhippurate/Creatinine [Molar ratio] in Urine mmol/mol
Indent82885-5 Meta methylhippurate [Moles/volume] in Urine umol/L
Indent82888-9 Ortho methylhippurate/Creatinine [Molar ratio] in Urine mmol/mol
Indent82887-1 Ortho methylhippurate [Moles/volume] in Urine umol/L
Indent82892-1 Para methylhippurate/Creatinine [Molar ratio] in Urine mmol/mol
Indent82891-3 Para methylhippurate [Moles/volume] in Urine umol/L
Indent82890-5 Meta methylhippurate+Ortho methylhippurate+Para methylhippurate/Creatinine [Molar ratio] in Urine mmol/mol
Indent82889-7 Meta methylhippurate+Ortho methylhippurate+Para methylhippurate [Moles/volume] in Urine umol/L

Fully-Specified Name

Component
Meta methylhippurate & ortho methylhippurate & para methylhippurate & Creatinine panel
Property
-
Time
Pt
System
Urine
Scale
-
Method

Additional Names

Short Name
Methylhippurates + creat Pnl Ur
Display Name
Meta methylhippurate and ortho methylhippurate and para methylhippurate and creatinine panel (U)
Consumer Name Alpha Get Info
Meta methylhippurate and Ortho methylhippurate and Para methylhippurate and Creatinine panel, Urine

Basic Attributes

Class
PANEL.DRUG/TOX
Type
Laboratory
First Released
Version 2.58
Last Updated
Version 2.58
Order vs. Observation
Order
Panel Type
Panel

Language Variants Get Info

Tag Language Translation
es-ES Spanish (Spain) Panel de Meta metilhipúrico+Orto metilhipúrico+Para metilhupúrico+creatinina:Propiedades mixtas (sólo paneles):Punto temporal:Orina:-:
es-MX Spanish (Mexico) Panel de metametilhipurato y ortometilhipurato y parametilhipurato y creatinina:-:Punto temporal:Orina:-:
fr-FR French (France) Méta méthylhippurate et ortho méthylhippurate et para méthylhippurate et créatinine panel:-:Ponctuel:Urine:-:
it-IT Italian (Italy) Meta metilippurato & orto metilippurato & para metilippurato & creatinina, panel:-:Pt:Urine:-:
Synonyms: Livelli farmacologici e tossicologia Panel meta metilippurato e orto metilippurato e pa Punto nel tempo (episodio) Set di prescrizione per livelli farmacologici e to
nl-NL Dutch (Netherlands) eta-methylhippuraat & ortho-methylhippuraat & para-methylhippuraat & creatinine panel:-:moment:urine:-:
Synonyms: kreatinine
zh-CN Chinese (China) 间甲基马尿酸与邻甲基马尿酸与对甲基马尿酸与肌酐组套:-:时间点:尿液:-:
Synonyms: 3-甲基马尿酸 4-甲基马尿酸;p-甲基马尿酸;对-甲基马尿酸 CR;Creat;肌氨酸酐;肌酸内酰胺;肌酸酐 Meta 甲基马尿酸 Meta-甲基马尿酸 M-甲基马尿酸 UCr 二甲苯代谢产物 医嘱套餐 医嘱套餐类 医嘱套餐组 医嘱组 医嘱组.药物/毒理学试验;组套（组合、医嘱组、套餐、套餐医嘱、医嘱套餐、组合申请、组合项目）.药物/毒理学;医嘱组.药物与毒理学;医嘱组.药物与毒理学试验;医嘱组类.药物/毒理学;医嘱组类.药物/毒理学试验;医嘱组类.药物与毒理学;医嘱组类.药物与毒理学试验;实验室医嘱组类.药物/毒理学;实验室医嘱组类.药物/毒理学试验;实验室医嘱组类.药物与毒理学;实验室医嘱组类.药物与毒理学试验;药物与毒理学医嘱组;药物与毒理学医嘱组类 医嘱组合 医嘱组合类 医嘱组套 医嘱组套类 医嘱组类 多重;多重型;多重标尺类型;多重精度类型 套餐 套餐医嘱 套餐医嘱组 套餐医嘱组类 实验室医嘱套餐 实验室医嘱套餐类 实验室医嘱组 实验室医嘱组合类 实验室医嘱组套 实验室医嘱组套类 实验室套餐医嘱组 实验室套餐医嘱组类 实验室检验项目医嘱组合类 实验室检验项目组合类 尿;小便;下泉 尿液肌酐 尿液肌酸酐 尿肌酸酐 时刻;随机;随意;瞬间 检验医嘱组合类 检验项目医嘱组合类 检验项目组合类 毒品 毒品类 组 组合 组合医嘱 组合类 组套 肌酐（肌酸酐）组套（组合、医嘱组、套餐、套餐医嘱、医嘱套餐、组合申请、组合项目） 药品类 药物 药物/毒理学;药物/毒理学试验;药物毒理学试验;药物毒理学试验类 药物类 邻-甲基马尿酸;邻位甲基马尿酸;邻位-甲基马尿酸;o-MHA 间-甲基马尿酸 间甲基马尿酸（间-甲基马尿酸、间位甲基马尿酸、间位-甲基马尿酸、m-MHA）+邻甲基马尿酸（邻-甲基马尿酸、邻位甲基马尿酸、邻位-甲基马尿酸、o-MHA）+对甲基马尿酸（对-甲基马尿酸、对位甲基马尿酸、对位-甲基马尿酸、p-MHA） 间甲基马尿酸（间-甲基马尿酸、间位甲基马尿酸、间位-甲基马尿酸、m-MHA）与邻甲基马尿酸（邻-甲基马尿酸、邻位甲基马尿酸、邻位-甲基马尿酸、o-MHA）与对甲基马尿酸（对-甲基马尿酸、对位甲基马尿酸、对位-甲基马尿酸、p-MHA）与肌酐组套（组合、医嘱组、套餐、套餐医嘱、医嘱套餐、组合申请、组合项目） 间-甲基马尿酸;间位甲基马尿酸;间位-甲基马尿酸;m-MHA 间甲马尿酸

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=85097-4
Questionnaire definition
https://fhir.loinc.org/Questionnaire/?url=http://loinc.org/q/85097-4